Prostate apoptosis response gene-4 sensitizes neoplastic lymphocytes to CD95-induced apoptosis
Marion Bergmann1, Natasa Kukoc-Zivojnov, Kai U Chow
1Department of Medicine III, Johann Wolfgang Goethe-University Hospital, Theodor-Stern-Kai-7, 60590, Frankfurt am Main, Germany.
Abstract:
Evaluating the functional consequences of prostate apoptosis response gene-4 (par-4) expression in CD95-induced apoptosis of neoplastic lymphocytes, we demonstrate that par-4 increases apoptosis by upregulating the CD95 receptor on the cell surface and--with a concomitant decrease of the FLICE-like inhibitory protein (FLIP)--by promoting cleavage of the initiator caspases-8 and -10. This results in an enforced activation of the executioner caspases-6, -7, and -3 as well as in an activation of the mitochondrial pathway. Upon inhibition of caspase-8, overexpression of par-4 enables Jurkat cells to maintain a higher sensitivity to CD95-induced apoptosis by downregulating cIAP-2 and XIAP and by enforcing activation of the initiator caspase-10 as well as of the executioner caspases-6, -7, and -3.
Insights
Prostate apoptosis response gene-4 (PAR-4) enhances CD95-induced apoptosis in lymphocytes by upregulating CD95 and downregulating FLIP. This promotes caspase activation and cell death, offering a potential therapeutic target.
Area of Science:
- Molecular Biology
- Immunology
- Cell Biology
Background:
- Prostate apoptosis response gene-4 (PAR-4) is implicated in apoptosis.
- CD95 (Fas receptor) signaling mediates apoptosis in lymphocytes.
- Dysregulation of apoptosis is a hallmark of neoplastic lymphocytes.
Purpose of the Study:
- To investigate the functional role of PAR-4 in CD95-induced apoptosis of neoplastic lymphocytes.
- To elucidate the molecular mechanisms by which PAR-4 influences CD95 signaling pathways.
Main Methods:
- Overexpression of PAR-4 in Jurkat T-cell lines.
- Analysis of CD95 receptor expression and FLICE-like inhibitory protein (FLIP) levels.
- Assessment of initiator and executioner caspase activation (caspases-8, -10, -6, -7, -3).
- Evaluation of mitochondrial pathway activation.
- Inhibition of caspase-8 to study compensatory mechanisms.
Main Results:
- PAR-4 overexpression upregulates cell surface CD95 receptor expression.
- PAR-4 decreases FLIP levels, promoting cleavage of caspases-8 and -10.
- Enforced activation of executioner caspases (-6, -7, -3) and mitochondrial pathway.
- Inhibition of caspase-8 by PAR-4 leads to sustained apoptosis sensitivity via caspase-10 activation and downregulation of cIAP-2 and XIAP.
Conclusions:
- PAR-4 significantly enhances CD95-induced apoptosis in neoplastic lymphocytes.
- PAR-4 modulates key components of the extrinsic and intrinsic apoptosis pathways.
- Targeting PAR-4 may represent a novel therapeutic strategy for lymphocyte malignancies.
Related Concept Videos
The Intrinsic Apoptotic Pathway
The Extrinsic Apoptotic Pathway
Abnormal Proliferation

